Touyun Biotech Group Limited (HKG:1332)

Touyun Biotech Group Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 12, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	356	522	645	1,207	3,704	2,080
Market Cap Growth	-35.86%	-19.13%	-46.51%	-67.42%	78.05%	277.47%
Enterprise Value	903	1,017	1,090	1,623	4,137	2,030
Last Close Price	0.13	0.19	0.23	0.43	1.32	0.75
PS Ratio	2.48	3.26	3.25	3.82	13.07	10.06
PB Ratio	-57.78	-12.84	30.63	4.26	7.61	3.74
P/TBV Ratio	-	-	-	4.58	7.89	4.34
P/OCF Ratio	-	-	295.63	-	-	-
EV/Sales Ratio	6.29	6.36	5.49	5.14	14.59	9.82
EV/FCF Ratio	-18.35	-	-	-	-	-
Debt / Equity Ratio	-81.11	-11.85	22.75	1.73	0.85	0.58
Net Debt / Equity Ratio	-79.24	-10.04	20.68	1.20	0.64	0.11
Net Debt / EBITDA Ratio	-11.36	-12.24	-6.10	-11.24	-9.04	-1.19
Net Debt / FCF Ratio	-9.93	-7.63	-29.15	-8.65	-1.43	-0.42
Asset Turnover	0.24	0.28	0.27	0.33	0.28	0.22
Inventory Turnover	5.05	4.41	5.69	5.72	5.31	3.86
Quick Ratio	0.09	0.22	0.26	0.53	0.36	0.81
Current Ratio	0.20	0.31	0.43	0.79	0.51	1.15
Return on Equity (ROE)	-	-	-178.98%	-52.60%	-23.76%	-31.24%
Return on Assets (ROA)	-5.94%	-5.04%	-7.54%	-2.77%	-2.39%	-3.69%
Return on Invested Capital (ROIC)	-11.67%	-11.32%	-16.69%	-5.97%	-5.39%	-9.03%
Return on Capital Employed (ROCE)	4006.20%	608.80%	-39.80%	-8.90%	-7.70%	-9.70%
Earnings Yield	-8.11%	-16.88%	-41.67%	-16.42%	-1.97%	-8.11%
FCF Yield	-13.80%	-10.26%	-2.32%	-3.26%	-5.87%	-6.77%
Buyback Yield / Dilution	-	-	-	-0.39%	-4.58%	-9.11%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.